Risk adjusted net present value: What is the current valuation of Aquestive Therapeutics’s Epinephrine?

Epinephrine is a small molecule commercialized by Aquestive Therapeutics, with a leading Phase III program in Anaphylaxis.

Apellis and Sobi land another late-stage win for rare kidney disease drug

Empaveli, the kidney disease drug from Apellis Pharmaceuticals and Sobi, reported a Phase 3 trial success that could help the treatment keep pace with a

August 9, 2024

Laxxon Medical to Showcase LXM.2, a Novel 3D Printed GLP-1 Agonist at BIO 2024 – Biotech Investments

New York, 05/16/2024 / 09:00, EST/EDT – EQS Newswire – Laxxon Medical NEW YORK, NY / ACCESSWIRE / May 16, 2024 / Laxxon Medical, a

May 17, 2024

Tennr Raises $18M to Fix Fax Problem in Healthcare with AI

Co-Founders Trey Holterman (CEO), Diego Baugh (CPO), Tyler Johnson (CTO) (Left to Right) What You Should Know: – Tennr, a New York-based company that automates

March 27, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.